The COVID-19 Pandemic – A Diagnostic Industry Perspective
Authors:
Open Access
- 24 March 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 12, 862440
Abstract
The COVID-19 pandemic has brought about unprecedented changes to all facets of the healthcare system, including the diagnostic industry. The pandemic has highlighted both the challenges and strengths of the industry and has also provided valuable insights on how to be better prepared for future pandemics. In this perspective article, we describe the challenges faced by the diagnostic industry in general, particularly the difficulties encountered by Luminex Corporation, a diagnostic assay development and manufacturing company located in Austin, Texas, USA, as well as the mitigation strategies employed. In addition to discussion of the key challenges, the article provides insights on the lessons learned and steps that can be undertaken to better prepare for future outbreaks.Keywords
This publication has 4 references indexed in Scilit:
- Balancing Quality and Speed in the Market Approval of Diagnostic TestsJAMA Health Forum, 2021
- The Importance of Diagnostic Testing during a Viral Pandemic: Early Lessons from Novel Coronavirus Disease (COVID-19)The American Journal of Tropical Medicine and Hygiene, 2020
- The Novel Coronavirus (SARS-CoV-2) Pandemic2020
- The Novel Coronavirus (SARS-CoV-2) PandemicAnnals of the Academy of Medicine, Singapore, 2020